Immune tolerance the resulting effect is similar. Immune tolerance is important for normal physiology. Central tolerance is the main way the immune system learns to discriminate self from non-self. Peripheral tolerance is key to preventing over-reactivity of the immune system to various environmental entities (allergens, gut microbes, etc.). Deficits in central or peripheral tolerance also cause autoimmune disease, resulting in syndromes such as systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, autoimmune polyendocrine syndrome type 1 (APS-1), and immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX), and potentially contribute to asthma, allergy, and inflammatory bowel disease. And immune tolerance in pregnancy is what allows
Human Tissue Authority Human Tissue Authority The Human Tissue Authority (HTA) is an executive non-departmental public body of the Department of Health of the United Kingdom. It regulates the removal, storage, use and disposal of human bodies, organs and tissue for a number of scheduled purposes such as research, transplantation, and education and training. It was created by the Human Tissue Act 2004 and came into being on 1 April 2005 and its statutory functions began on 1 April 2006. The authority was originally chaired by Baroness Hayman followed, in 2006, by Shirley Harrison, from January 2010-2018 by Baroness Diana Warwick and since